The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Long‐acting muscarinic antagonist regulates group 2 innate lymphoid cell‐dependent airway eosinophilic inflammation - Matsuyama - 2021 - Allergy - Wiley Online Library
Management of chronic obstructive pulmonary disease: Insights into patient profile – Use of inhaled corticosteroids/long-acting β2-Agonists or long- acting β2-agonists/long-acting muscarinic antagonists Kishore N, Moitra S, Sircar M - Indian J Respir Care
inhaled drugs for asthma and COPD | Download Table
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chro | JEP
New COPD Medications - AARC
A Review of the 2019 GOLD Guidelines for COPD
Efficacy and cardiovascular safety of LAMA in patients with COPD: a systematic review and meta-analysis | Journal of Investigative Medicine
COPD: Managing Medications - CareOregon MEDS Ed seminar (2/6) - YouTube
Pharmacological management of COPD .SABA = short-acting beta 2... | Download Scientific Diagram
Management of chronic obstructive pulmonary disease: Insights into patient profile – Use of inhaled corticosteroids/long-acting β2-Agonists or long- acting β2-agonists/long-acting muscarinic antagonists Kishore N, Moitra S, Sircar M - Indian J Respir Care
Understanding the role of long-acting muscarinic antagonists in asthma treatment - Annals of Allergy, Asthma & Immunology
Long‑acting muscarinic antagonist and long‑acting β2‑agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery
Therapeutic Class Overview
Management of stable COPD. SABA, short-acting bronchodilator agonist;... | Download Scientific Diagram
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial - The Lancet
Algorithm showing use of inhaled therapies. FEV 1 , forced expiratory... | Download Scientific Diagram
Cureus | Trends in Inhaler Prescriptions and Associated Cost in the United States From 2014 to 2018: An Analysis From the Medicare Part D Database
Inhaled long-acting muscarinic antagonists in asthma – A narrative review - ScienceDirect
Preclinical Evaluation of Long-Acting Muscarinic Antagonists: Comparison of Tiotropium and Investigational Drugs | Journal of Pharmacology and Experimental Therapeutics
Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium
LAMA - "Long-Acting Muscarinic Antagonists" by AcronymsAndSlang.com
